English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

DOI:10.14744/bej.2018.29491 Beyoglu Eye J 2018; 3(3): 109-115 Original Article Balta et al., Multifocal electroretinography in diabetic patients 110 Palmowski et al. (5) found that in patients with diabetes mfERG amplitudes were reduced and implicit times were increased compared to healthy peoples. Harrison et al. found that mfERG implicit time is a good predictor of DR onset in patients with diabetes without DR (6). The ability of the mfERG findings to predict the future retinopathy provides clinicians a good tool to screen, follow-up, and even consider early prophylactic treatment of the patients with DR (7). As shown by many studies, preventing elevated blood glucose significantly reduces the risk of ocular and visual complications of diabetes (8–11). Kahn and Bradley found a strong positive association between retinopathy and duration of diabetes in a random sample of 914 diabetic patients (12). Among younger-onset patients with diabetes, the prevalence of any retinopathy was 8% at first 3 years, 25% at 5 years, 60% at 10 years, and 80% at 15 years. The prevalence of proliferative DR was 0% at first 3 years and increased to 25% at 15 years. The 4-year incidence of developing proliferative retinopathy in the younger-onset group increased from 0% during the first 5 years to 27.9% during years 13–14 of diabetes (13). The aims of this study were to compare mfERG findings (N1–P1 amplitude and P1-implicit time) in diabetic patients without DR who had different HbA1c levels to healthy control participants without diabetes and to assess the correlation mfERG responses with diabetes duration.

Multifocal Electroretinography in Diabetic Patients without Retinopathy